SG11201600901VA - Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same - Google Patents

Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same

Info

Publication number
SG11201600901VA
SG11201600901VA SG11201600901VA SG11201600901VA SG11201600901VA SG 11201600901V A SG11201600901V A SG 11201600901VA SG 11201600901V A SG11201600901V A SG 11201600901VA SG 11201600901V A SG11201600901V A SG 11201600901VA SG 11201600901V A SG11201600901V A SG 11201600901VA
Authority
SG
Singapore
Prior art keywords
hydroxytyrosol
promoting
derivatives
agent
same
Prior art date
Application number
SG11201600901VA
Other languages
English (en)
Inventor
Toshiya Ueno
Masaru Kominami
Naoki Kasajima
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11201600901VA publication Critical patent/SG11201600901VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
SG11201600901VA 2013-08-09 2014-08-07 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same SG11201600901VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013166606 2013-08-09
JP2014087023 2014-04-21
PCT/JP2014/070839 WO2015020138A1 (fr) 2013-08-09 2014-08-07 Agent pour favoriser l'absorption in vivo d'hydroxytyrosol et de ses dérivés, et son utilisation

Publications (1)

Publication Number Publication Date
SG11201600901VA true SG11201600901VA (en) 2016-03-30

Family

ID=52461467

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201800500UA SG10201800500UA (en) 2013-08-09 2014-08-07 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same
SG11201600901VA SG11201600901VA (en) 2013-08-09 2014-08-07 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201800500UA SG10201800500UA (en) 2013-08-09 2014-08-07 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same

Country Status (14)

Country Link
US (1) US20160184434A1 (fr)
EP (1) EP3075379A4 (fr)
JP (2) JP6405310B2 (fr)
KR (1) KR20160042017A (fr)
CN (1) CN105451728A (fr)
AU (1) AU2014303393B2 (fr)
CA (1) CA2920601C (fr)
HK (1) HK1218879A1 (fr)
MY (1) MY179576A (fr)
NZ (1) NZ716858A (fr)
RU (1) RU2016107746A (fr)
SG (2) SG10201800500UA (fr)
TW (1) TWI674893B (fr)
WO (1) WO2015020138A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106511108B (zh) * 2016-12-15 2019-06-14 天津市益倍建生物技术有限公司 一种含白藜芦醇的美白补水面膜泥及其制备方法与应用
JP6901274B2 (ja) * 2017-02-14 2021-07-14 株式会社ファンケル ω３系脂肪酸吸収促進用組成物
US20200281834A1 (en) * 2017-09-29 2020-09-10 Suntory Holdings Limited Composition for promoting expression of aquaporin 3, and use thereof
JP7323276B2 (ja) * 2018-10-19 2023-08-08 サントリーホールディングス株式会社 容器詰飲料
CN111286205A (zh) * 2019-12-17 2020-06-16 陕西科技大学 一种具有抗氧化活性及沙门氏菌检测能力的羟基酪醇鲟鱼鱼皮明胶薄膜及其制备方法
AU2021228197A1 (en) * 2020-02-28 2022-07-07 Biosearch, S.A. Uses and compositions based on polyphenols for improving the oral bioavailability of hydroxytyrosol
CN112198269A (zh) * 2020-04-22 2021-01-08 山东省药学科学院 一种测定Beagle犬血浆中羟基酪醇的方法
CN115039880A (zh) * 2022-07-01 2022-09-13 上海益跬尔生物科技有限公司 一种改善代谢衰老和炎症衰老的组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3650245B2 (ja) 1997-02-27 2005-05-18 御木本製薬株式会社 美白化粧品
DE60031921T2 (de) 1999-08-16 2007-09-20 Dsm Ip Assets B.V. Verfahren zu Herstellung von Epigallocatechin Gallate
JP4659407B2 (ja) 2004-07-29 2011-03-30 サントリーホールディングス株式会社 オリゴメリックプロアントシアニジン（ｏｐｃ）の分析方法
ITMI20051485A1 (it) 2005-07-29 2007-01-30 Indena Spa Estratto da semi d'uva ottenibile per frazionamento su resina
KR20080105023A (ko) * 2005-10-14 2008-12-03 디에스엠 아이피 어셋츠 비.브이. 근육 소모의 치료를 위한 기능성식품 조성물
CN101312718A (zh) * 2005-10-14 2008-11-26 帝斯曼知识产权资产管理有限公司 用于治疗肌肉消瘦的营养药物性组合物
JP5339373B2 (ja) * 2006-07-14 2013-11-13 ディーエスエム アイピー アセッツ ビー．ブイ． 組成物および炎症障害の治療、共治療または予防のためのその使用
EP1897530A1 (fr) * 2006-09-08 2008-03-12 DSMIP Assets B.V. Composition de soin dermatologique
JP2008094754A (ja) * 2006-10-11 2008-04-24 En Otsuka Pharmaceutical Co Ltd 糖尿病または血糖コントロール用栄養組成物
JP5634666B2 (ja) 2008-07-01 2014-12-03 森永製菓株式会社 ポリフェノール類化合物の吸収促進用組成物
JP5043783B2 (ja) 2008-08-26 2012-10-10 株式会社神戸製鋼所 インパネ補強材およびその取り付け方法
FR2942224B1 (fr) * 2009-02-18 2012-11-30 Centre De Cooperation Internationale En Rech Agronomique Pour Le Developpement Cirad Procede d'extraction de composes phenoliques a partir d'eau de vegetation de l'olive et preparation d'extrait titre en polyphenols d'olive et de raisin
EP2263481A1 (fr) * 2009-05-29 2010-12-22 Nestec S.A. Extraits de thé vert de biodisponibilité améliorée
JP5610736B2 (ja) 2009-10-06 2014-10-22 森永製菓株式会社 ポリフェノール類化合物の吸収促進用の医薬組成物、ポリフェノール類化合物を含有する飲食品又は飲食品素材の製造方法及びポリフェノール類化合物を含有する飲食品又は飲食品素材

Also Published As

Publication number Publication date
KR20160042017A (ko) 2016-04-18
CA2920601A1 (fr) 2015-02-12
JPWO2015020138A1 (ja) 2017-03-02
EP3075379A1 (fr) 2016-10-05
SG10201800500UA (en) 2018-03-28
JP2018196381A (ja) 2018-12-13
MY179576A (en) 2020-11-11
US20160184434A1 (en) 2016-06-30
AU2014303393B2 (en) 2019-11-28
TW201601711A (zh) 2016-01-16
HK1218879A1 (zh) 2017-03-17
AU2014303393A1 (en) 2016-03-24
CN105451728A (zh) 2016-03-30
NZ716858A (en) 2020-02-28
TWI674893B (zh) 2019-10-21
RU2016107746A (ru) 2017-09-11
JP6405310B2 (ja) 2018-10-17
WO2015020138A1 (fr) 2015-02-12
CA2920601C (fr) 2021-07-27
EP3075379A4 (fr) 2017-02-08

Similar Documents

Publication Publication Date Title
IL304851A (en) Tazematostat in combination with an acceptable treatment factor for use in the treatment of cancer
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
HK1218879A1 (zh) 羥基酪醇及其衍生物的體內吸收促進劑及其利用
PT3004108T (pt) Derivados de pirazolo-pirrolidin-4-ona como inibidores de bet e a sua utilização no tratamento de doenças
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
EP2977052A4 (fr) Agent destiné à une maladie liée au style de vie et composition orale le comprenant
HK1222562A1 (zh) 用於醫學診斷的組合物及方法
IL237125A0 (en) Use of preparations containing niclosamide and/or its derivatives for the treatment of solid tumors
HK1223607A1 (zh) 作爲抗病毒劑的咪唑衍生物及其製藥用途
EP2991627A4 (fr) Composition de succédané de sang et procédé d'utilisation
HK1224175A1 (zh) 用於減少痂形成並促進癒合的組合物
HK1212255A1 (en) Artemisinin and its derivatives for use in the treatment of kidney disease
IL233875A (en) Preparation and use for the treatment of anal fissures
SG11201600013WA (en) Systems and methods for in vivo irradiation of blood
EP2868727A4 (fr) Agent absorbant dans l'infrarouge proche et composition absorbant dans l'infrarouge proche
SG11201601628VA (en) Photoacoustic imaging contrast agent composition
EP2985024A4 (fr) Agent thérapeutique pour maladie osseuse systémique et utilisation associée
EP2984170A4 (fr) Utilisation de conjugués anticorps-uréase pour applications diagnostiques et thérapeutiques
GB201308753D0 (en) Compounds and their use in therapy
EP2986112A4 (fr) Préparation et utilisation de dérivés d'acide fulvique
GB201515643D0 (en) Improvements in or relating to assemblies for use in knee replcement surgery
HK1209033A1 (zh) 奧地帕西在治療黏多醣症病中的應用
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB201308217D0 (en) Compounds and their use in therapy
TH1401007652A (th) อะมิโนไตรอะโซโลไพริดีนสำหรับการใช้ในการรักษาการอักเสบ และองค์ประกอบทางเภสัชกรรมของมัน